HEARTio -Helping Clinicians Identify Cardiovascular Disease Faster

HEARTio is a digital diagnostic startup utilizing artificial intelligence in conjunction with the electrocardiogram to help clinicians identify cardiovascular disease more quickly, more accurately, and at a fraction of the cost.


  • ECGio is a stronger diagnostic tool that takes seconds to use, without the need for specialized training or workflow adjustments.
  • For Clinicians: Superior diagnostic power without the need for radiation.
  • For Clinicians: Non-disruptive to the traditional workflow that is simple to use.
  • For Clinicians and Patients: Fraction of the cost of invasive testing for similar interpretation.
  • For Payors: Fewer repeat admissions with better outpatient monitoring and highly specific to minimize serial testing.

Main Features

  • Today there is no one test for the determination of coronary artery disease at the point-of-care. We are looking to change that.
  • HEARTio is bringing the power of AI to the first cardiovascular test in the diagnostic pathway, the electrocardiogram (ECG).
  • HEARTio’s flagship product, ECGio, is an AI platform that brings the power of deep learning to a clinician’s fingertips.
  • ECGio’s diagnostic power rivals that of further downstream testing in validation studies in predicting the presence, and severity of CAD.
  • We use data from ECGs to develop deep learning algorithms focused on individualized predictions by identifying arterial stenosis.

Primary Audience

  • Healthcare Industry
  • Medical insurance Industry
  • Patients with heart disease and issues